ustransplant.org -- Transplant Statistics Reference Tables

Transplant Statistics: Annual Report : Reference Tables

Table 5.6d

Immunosuppression Use: Antirejection Treatment from Transplant

to One Year Post Transplant, 1991 to 2000

Recipients with Kidney Transplants

		Year of Transplant
		1991	1992	1993	1994	1995	1996	1997	1998	1999	2000
Transplants		9,674	9,737	10,359	10,645	11,060	11,364	11,675	12,376	12,570	13,404
Tx with Antirejection Treatments		3,729	3,655	3,961	3,366	4,317	5,797	3,382	2,465	2,269	2,221
Antibodies	Category Usage	54.4%	53.0%	57.2%	53.3%	32.1%	16.8%	27.5%	37.4%	37.4%	37.5%
	ALG	19.6%	19.5%	20.6%	18.7%	5.8%	0.3%	0.0%	0.0%	0.0%	0.0%
	ATG	0.4%	0.7%	0.4%	0.6%	2.0%	2.8%	5.8%	7.5%	5.2%	2.9%
	NRATG/NRATS	0.0%	0.0%	0.0%	0.0%	0.2%	0.6%	0.7%	1.1%	1.1%	0.1%
	OKT3	40.1%	39.3%	43.9%	43.0%	26.6%	13.9%	22.0%	28.0%	19.8%	15.5%
	Thymoglobulin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.2%	1.0%	8.2%	13.5%
	Zenapax	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.2%	1.8%	4.4%	3.6%
	Simulect	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	1.5%	4.3%
Corticosteroids	Category Usage	82.9%	80.7%	81.0%	78.6%	57.9%	37.5%	57.8%	77.0%	76.9%	79.1%
	Prednisone	31.8%	27.7%	24.5%	20.4%	12.8%	8.6%	13.5%	19.1%	24.6%	29.9%
	Methylprednisolone	65.1%	65.2%	69.6%	69.8%	51.8%	33.5%	50.4%	65.1%	60.5%	58.2%

Source: OPTN/SRTR Data as of August 1, 2002.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may be prescribed more than one drug within the same category.

Center-Specific Reports | OPO Reports | National Reports | Data Accuracy | Report Timeline

SRTR Site designed and maintained by Diamond Bullet Design & URREA.